MUFG Securities Americas’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
2,210
+59
+3% +$37.8K 0.08% 226
2025
Q4
$1.46M Sell
2,151
-7
-0.3% -$4.77K 0.09% 196
2025
Q3
$1.38M Buy
2,158
+376
+21% +$228K 0.09% 203
2025
Q2
$956K Buy
1,782
+332
+23% +$159K 0.08% 221
2025
Q1
$609K Buy
1,450
+241
+20% +$105K 0.07% 248
2024
Q4
$500K Buy
+1,209
New +$530K 0.06% 262

Other funds holding IDXX

MUFG Securities Americas's IDXX Position: Q1 2026 in Review

MUFG Securities Americas increased its Idexx Laboratories (IDXX) stake by 2.7% in Q1 2026, buying an estimated $37.8K and bringing the position to 2,210 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #226.

MUFG Securities Americas first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.46M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • MUFG Securities Americas held 2,210 shares of Idexx Laboratories worth $1.24M as of Q1 2026.
  • MUFG Securities Americas bought 59 Idexx Laboratories shares in Q1 2026, an estimated $37.8K.
  • Idexx Laboratories made up 0.08% of MUFG Securities Americas's portfolio in Q1 2026, its #226 holding.
  • MUFG Securities Americas first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's Idexx Laboratories position peaked at $1.46M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.